{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05776069",
            "orgStudyIdInfo": {
                "id": "VGA039-CP001"
            },
            "organization": {
                "fullName": "Vega Therapeutics, Inc",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease",
            "officialTitle": "A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of VGA039 Following IV or SC Administration of Single Ascending Doses in Healthy Adults and Subcutaneous Adult Patients With Von Willebrand Disease",
            "therapeuticArea": [
                "Other"
            ],
            "study": "study-of-in-healthy-volunteers-and-patients-with-von-willebrand-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-16",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-03-08",
            "studyFirstSubmitQcDate": "2023-03-08",
            "studyFirstPostDateStruct": {
                "date": "2023-03-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-16",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Vega Therapeutics, Inc",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a multi-center, Phase 1a study to assess the safety, tolerability, PK, and PD of VGA039 following single IV or SC dose administration in healthy subjects and Von Willebrand disease patients.",
            "detailedDescription": "This first in human study consists of 2 parts based on the subject population: Part 1 and Part 2. Part 1 is a randomized, double-blind, placebo-controlled, single ascending dose (SAD) evaluation of IV or SC VGA039 or placebo in up to 8 cohorts. Part 2 is an open-label, SAD of SC and IV VGA039 in up to 8 cohorts. All participants will be enrolled, treated, and followed up for 15 weeks (IV SAD) or 8 weeks(SC SAD)."
        },
        "conditionsModule": {
            "conditions": [
                "Von Willebrand Diseases"
            ],
            "keywords": [
                "Von Willebrand Disorder"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 64,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Part 1",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Cohorts 1-8 IV or SC VGA039 or Placebo dose to be determined",
                    "interventionNames": [
                        "Drug: VGA039",
                        "Other: Placebo"
                    ]
                },
                {
                    "label": "Part 2",
                    "type": "EXPERIMENTAL",
                    "description": "Cohorts A-H IV or SC VGA039 dose to be determined",
                    "interventionNames": [
                        "Drug: VGA039"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "VGA039",
                    "description": "Single doses of VGA039",
                    "armGroupLabels": [
                        "Part 1",
                        "Part 2"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo",
                    "description": "Single doses of Placebo",
                    "armGroupLabels": [
                        "Part 1"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of Treatment-Emergent Adverse Events [Safety and tolerability]",
                    "description": "Incidence, nature and severity of adverse events (AEs) and serious adverse events (SAEs), including dose-limiting toxicities (DLTs).",
                    "timeFrame": "From start of study drug administration until 15 or 8 weeks after IV or SC study drug administration, respectively"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Plasma Concentrations of single IV and SC doses of VGA039",
                    "timeFrame": "From baseline until 15 or 8 weeks after IV or SC study drug administration, respectively"
                },
                {
                    "measure": "Pharmacodynamics of single IV and SC doses of VGA039",
                    "timeFrame": "From baseline until 15 or 8 weeks after IV or SC study drug administration, respectively"
                },
                {
                    "measure": "Incidence of Anti-drug antibodies to VGA039",
                    "timeFrame": "From baseline until 15 or 8 weeks after IV or SC study drug administration, respectively"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria (All Subjects)\n\n* Subjects, 18 to 60 years of age, inclusive.\n* No clinically significant laboratory, ECG, or vital signs results.\n\nAdditional Key Inclusion Criteria (for Subjects in Part 1 Only) \u2022 Body mass index of 18-32 kg/m2\n\nAdditional Key Inclusion Criteria (for Subjects in Part 2 Only)\n\n* Subjects with VWD who are symptomatic, defined as having a history of bleeding or bruising.\n* Hemoglobin level \u2265 8 g/dL and platelet count \u2265 150 \u00d7 109/L at Screening.\n\nExclusion Key Criteria (All Subjects)\n\n* Use of hormonal contraceptives within 56 days prior to administration of the study drug.\n* Subjects with detection of FV Leiden or Prothrombin G20210A mutation, protein C or S deficiency, antithrombin deficiency, or antiphospholipid antibody syndrome at Screening.\n* Subjects with other known pro-thrombotic disorders or abnormal findings in any prior laboratory thrombophilia evaluation.\n* History of arterial or venous thrombosis, including superficial thrombophlebitis, or embolism.\n* Evidence of renal, hepatic, central nervous system, respiratory, cardiovascular disease, cerebrovascular disease, peripheral vascular disease, or metabolic dysfunction.\n\nAdditional Key Exclusion Criterion (Subjects in Part 1 Only)\n\n\u2022 Baseline FVIII activity \\> 150 IU/dL.\n\nAdditional Key Exclusion Criteria (Subjects in Part 2 Only)\n\n* Baseline FVIII activity \\> 50 IU/dL.\n* Any acute, clinically significant bleeding event requiring surgical or procedural intervention within 7 days prior to receiving study drug.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "60 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trials",
                    "role": "CONTACT",
                    "phone": "650-466-8041",
                    "email": "info@vega-therapeutics.com"
                }
            ],
            "locations": [
                {
                    "facility": "Orthopedic Institute for Children (UCLA)",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90007",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "UC Davis Medical Center",
                    "status": "RECRUITING",
                    "city": "Sacramento",
                    "state": "California",
                    "zip": "95817",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.58157,
                        "lon": -121.4944
                    }
                },
                {
                    "facility": "University of Colorado School of Medicine",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Hemophilia Center of Western PA",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15213",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                },
                {
                    "facility": "Vanderbilt University Medical Center",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37232",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "University of Texas Southwestern",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75235",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Versiti Comprehensive Center for Bleeding Disorders",
                    "status": "RECRUITING",
                    "city": "Milwaukee",
                    "state": "Wisconsin",
                    "zip": "53233",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 43.0389,
                        "lon": -87.90647
                    }
                },
                {
                    "facility": "Medical University of Vienna",
                    "status": "RECRUITING",
                    "city": "Vienna",
                    "country": "Austria",
                    "geoPoint": {
                        "lat": 48.20849,
                        "lon": 16.37208
                    }
                },
                {
                    "facility": "Hemocentro Unicamp",
                    "status": "RECRUITING",
                    "city": "Campinas",
                    "state": "Sao Paulo",
                    "zip": "13083-878",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -22.90556,
                        "lon": -47.06083
                    }
                },
                {
                    "facility": "Centro de Hemoterapia e Hematologia do Rio de Janeiro HEMORIO",
                    "status": "RECRUITING",
                    "city": "Rio De Janeiro",
                    "zip": "20211-030",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -22.90278,
                        "lon": -43.2075
                    }
                },
                {
                    "facility": "Hospital das Clinicas - USP Endereco",
                    "status": "RECRUITING",
                    "city": "S\u00e3o Paulo",
                    "zip": "05403-010",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -23.5475,
                        "lon": -46.63611
                    }
                },
                {
                    "facility": "Hamilton Health Sciences Corporation",
                    "status": "RECRUITING",
                    "city": "Hamilton",
                    "state": "Ontario",
                    "zip": "L8N 3Z5",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.25011,
                        "lon": -79.84963
                    }
                },
                {
                    "facility": "Queens University",
                    "status": "RECRUITING",
                    "city": "Kingston",
                    "state": "Ontario",
                    "zip": "K7L 3N6",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 44.22976,
                        "lon": -76.48101
                    }
                },
                {
                    "facility": "St. Michaels Hospital",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M5B 1W8",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "K J Somaiya Super Speciality Hospital & Research Centre",
                    "status": "RECRUITING",
                    "city": "Sion",
                    "state": "Mumbai",
                    "zip": "400022",
                    "country": "India"
                },
                {
                    "facility": "Charlotte Maxeke Johannesburg Academic Hospital",
                    "status": "RECRUITING",
                    "city": "Johannesburg",
                    "country": "South Africa",
                    "geoPoint": {
                        "lat": -26.20227,
                        "lon": 28.04363
                    }
                },
                {
                    "facility": "Royal London Hospital, Clinical Haematology Research",
                    "status": "RECRUITING",
                    "city": "Whitechapel",
                    "state": "London",
                    "zip": "E12ES",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.51382,
                        "lon": -0.06583
                    }
                },
                {
                    "facility": "Royal Free Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "NW3 2QG",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Imperial College Healthcare NHS Trust- Queen Charlotte's & Chelsea Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014842",
                    "term": "Von Willebrand Diseases"
                }
            ],
            "ancestors": [
                {
                    "id": "D000025861",
                    "term": "Blood Coagulation Disorders, Inherited"
                },
                {
                    "id": "D000001778",
                    "term": "Blood Coagulation Disorders"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000020147",
                    "term": "Coagulation Protein Disorders"
                },
                {
                    "id": "D000001791",
                    "term": "Blood Platelet Disorders"
                },
                {
                    "id": "D000006474",
                    "term": "Hemorrhagic Disorders"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17585",
                    "name": "Von Willebrand Diseases",
                    "asFound": "Von Willebrand Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21977",
                    "name": "Hemostatic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5059",
                    "name": "Blood Coagulation Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M23095",
                    "name": "Blood Coagulation Disorders, Inherited",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M21982",
                    "name": "Coagulation Protein Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5072",
                    "name": "Blood Platelet Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M9560",
                    "name": "Hemorrhagic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                }
            ]
        }
    },
    "hasResults": false
}